32 related articles for article (PubMed ID: 21367676)
1. Simultaneous determination of 11 oral targeted antineoplastic drugs and 2 active metabolites by LC-MS/MS in human plasma and its application to therapeutic drug monitoring in cancer patients.
Zhao J; Yan D; Li Y; Xu X; Li F; Zhang S; Jin J; Qiu F
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Apr; 1237():124100. PubMed ID: 38547701
[TBL] [Abstract][Full Text] [Related]
2. LC-MS/MS method for quick detection of vonoprazan fumarate in human plasma: Development, validation and its application to a bioequivalence study.
Chen X; Chen T; Huang Y; Wang M; Wang Y; Wu P; Xia X; Du P; Wu J; Shen J; Jia Y
Biomed Chromatogr; 2024 Jun; 38(6):e5860. PubMed ID: 38558021
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantification of the acetyl-coenzyme A competitive p300/CBP catalytic inhibitor A-485 in biological samples.
Oertel R; Jaschke N; Lippert A; Renner B
Biomed Chromatogr; 2024 Apr; 38(4):e5819. PubMed ID: 38148286
[TBL] [Abstract][Full Text] [Related]
4. Magnetic solid phase extraction of Sunitinib malate in urine samples assisted with mixed hemimicelle and spectrophotometric detection.
Pourbasheer E; Malekpour L; Azari Z; Masand VH; Ganjali MR
Sci Rep; 2023 Feb; 13(1):3361. PubMed ID: 36849725
[TBL] [Abstract][Full Text] [Related]
5. Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib-Treated Cancer.
Diekstra MH; Fritsch A; Kanefendt F; Swen JJ; Moes D; Sörgel F; Kinzig M; Stelzer C; Schindele D; Gauler T; Hauser S; Houtsma D; Roessler M; Moritz B; Mross K; Bergmann L; Oosterwijk E; Kiemeney LA; Guchelaar HJ; Jaehde U
CPT Pharmacometrics Syst Pharmacol; 2017 Sep; 6(9):604-613. PubMed ID: 28571114
[TBL] [Abstract][Full Text] [Related]
6. A relative quantitative positive/negative ion switching method for untargeted lipidomics via high resolution LC-MS/MS from any biological source.
Breitkopf SB; Ricoult SJH; Yuan M; Xu Y; Peake DA; Manning BD; Asara JM
Metabolomics; 2017 Mar; 13(3):. PubMed ID: 28496395
[TBL] [Abstract][Full Text] [Related]
7. Localization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: a MALDI-MS imaging study.
Torok S; Vegvari A; Rezeli M; Fehniger TE; Tovari J; Paku S; Laszlo V; Hegedus B; Rozsas A; Dome B; Marko-Varga G
Br J Pharmacol; 2015 Feb; 172(4):1148-63. PubMed ID: 25363319
[TBL] [Abstract][Full Text] [Related]
8. Sunitinib LC-MS/MS Assay in Mouse Plasma and Brain Tissue: Application in CNS Distribution Studies.
Oberoi RK; Mittapalli RK; Fisher J; Elmquist WF
Chromatographia; 2013 Dec; 76(23-24):. PubMed ID: 24409000
[TBL] [Abstract][Full Text] [Related]
9. A positive/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue.
Yuan M; Breitkopf SB; Yang X; Asara JM
Nat Protoc; 2012 Apr; 7(5):872-81. PubMed ID: 22498707
[TBL] [Abstract][Full Text] [Related]
10. A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine.
Marangon E; Buzzo M; Posocco B; Gagno S; Zanchetta M; Iacuzzi V; Poetto AS; Guardascione M; Giodini L; Toffoli G
J Pharm Biomed Anal; 2020 Feb; 179():112949. PubMed ID: 31784210
[TBL] [Abstract][Full Text] [Related]
11. LC-MS/MS quantitation of antimalarial drug piperaquine and metabolites in human plasma.
Aziz MY; Hoffmann KJ; Ashton M
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1063():253-258. PubMed ID: 28863865
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of an LC-MS/MS method for the quantification of fascin proteins in human serum.
Li K; Zhang Z; Wang K; Huang XY; Lin ZJ
Bioanalysis; 2022 Aug; 14(16):1095-1109. PubMed ID: 36154676
[No Abstract] [Full Text] [Related]
13. Development and validation of a liquid chromatography/tandem mass spectrometry procedure for the quantification of sunitinib (SU11248) and its active metabolite, N-desethyl sunitinib (SU12662), in human plasma: application to an explorative study.
Rodamer M; Elsinghorst PW; Kinzig M; Gütschow M; Sörgel F
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(11-12):695-706. PubMed ID: 21367676
[TBL] [Abstract][Full Text] [Related]
14. Bioanalytical method for the quantification of sunitinib and its n-desethyl metabolite SU12662 in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometry.
de Bruijn P; Sleijfer S; Lam MH; Mathijssen RH; Wiemer EA; Loos WJ
J Pharm Biomed Anal; 2010 Mar; 51(4):934-41. PubMed ID: 19931354
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of unbound sunitinib and its metabolite N-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study.
Rais R; Zhao M; He P; Xu L; Deeken JF; Rudek MA
Biomed Chromatogr; 2012 Nov; 26(11):1315-24. PubMed ID: 22259028
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
